Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Updated: Jul 12, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

非侵入性框架核酸眼药滴用于视网膜施用.

Shitai Zhu^1,2, Qinglong Yan³, Lihua Wang^1,4,2

¹Division of Physical Biology, CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.

ACS applied bio materials

|October 20, 2023

概括

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Disruption of microtubules with low intensity ultrasound rescues hair follicle damage by paclitaxel in mouse models.

Nature communications·2026

Same author

Programmable Hierarchical Assembly of Atomically Precise Metal Nanoclusters Using Supra-Amphiphilic Nucleic Acids.

JACS Au·2026

Same author

DNA Framework Nucleator-Enabled Intelligent Hydrogel Interfaces on Living Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Localised Autophagy Inhibition by Nanodiamonds Potentiates Arsenic Therapy With Favourable Safety Profile in Solid Tumours.

Cell proliferation·2026

Same author

Cell Membrane Targeting via Spacer Length-Engineered Amphiphilic DNA Frameworks.

ACS applied bio materials·2026

Same author

Photoactivated Digital Recombinase Polymerase Amplification/CRISPR-Cas12a Assay for Point-of-Care of BK Polyomavirus Quantification.

ACS nano·2026

这项研究引入了用于非侵入性眼睛治疗的新型DNA纳米结构. 这些框架核酸 (FNA) 通过眼滴有效地将药物输送到视网膜,克服了目前的注射限制.

科学领域:

眼科医生眼科眼科
纳米技术纳米技术
生物医学工程生物医学工程

背景情况:

静脉内注射是治疗视网膜疾病的常见方法,但有显著的缺点.
这些包括眼部创伤,感染风险,以及由于频繁的药物管理,患者不适应治疗.
开发有效的非侵入性眼科药物输送到视网膜是具有挑战性的,因为视角膜等生物障碍.

研究的目的:

开发和评估尺寸和形状解析的光DNA框架,用于非侵入性视网膜药物输送.
评估这些纳米载体的效率和生物相容性,以便在视网膜中使用.

主要方法:

使用框架核酸 (FNA) 由于其生物相容性和可控制的纳米结构特性.
具有特定尺寸的工程四面体DNA纳米结构 (TDNs) (20bp边长).
在眼科背景下研究了这些TDN的视网膜传递效率和生物相容性.

主要成果:

具有20bp边长的四面体DNA纳米结构 (TDNs) 在6小时内证明了有效的视网膜透.
开发的基于FNA的纳米载体表现出极好的生物相容性.
优化FNA的大小和形状对于有效的非侵入性视网膜药物递送至关重要.

关键词:

框架核酸 (FNAs) 的框架.非侵入性的眼科眼滴.通过视网膜给药.形状形状形状形状尺寸大小尺寸大小尺寸大小尺寸大小四面体DNA纳米结构 (TDNs) 是一种

更多相关视频

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Intravitreal Injections in the Ovine Eye

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

相关实验视频

Last Updated: Jul 12, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Intravitreal Injections in the Ovine Eye

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

结论:

框架核酸为非侵入性视网膜药物递送提供了一个有希望的平台.
优化的DNA纳米结构可以克服眼睛的障碍,有效地到达视网膜.
这种方法为视网膜疾病的局部治疗提供了新的策略,改善了患者的遵守和安全.